REQUEST A DEMO
Total
USD $0.00
Search more companies

Agepha Pharma S.R.O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Agepha Pharma S.R.O. Profile Updated: July 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Agepha Pharma S.R.O. is an enterprise located in Slovakia, with the main office in Senec. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on August 26, 2010. It currently has a total number of 5 - 9 (2025) employees. From the latest financial highlights, Agepha Pharma S.R.O. reported a net sales revenue drop of 35.42% in 2025. Over the same period, its total assets grew by 105.99%.

Headquarters
Dialnicna cesta, 5
Senec; Bratislavsky; Postal Code: 90301

Contact Details: Purchase the Agepha Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Agepha Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Agepha Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Agepha Pharma S.R.O. report to view the information.
Incorporation Date:
August 26, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Agepha Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-35.42%▼
Total Operating Revenue
-35.19%▼
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
105.99%▲
Total Equity
17.22%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-11.75%▼
Cash Ratio
-1%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?